The risk for venous thromboembolism varies among different types of hormonal contraceptives. HealthDay News — Venous thromboembolism (VTE) risk varies across hormonal contraceptives, according to a ...

A fuller picture of protein S deficiency emerged with large-scale research showing the immense thrombotic risks faced by carriers of rare loss-of-function gene variants, though patients with ...

no study has examined the association between OA and risk of VTE. To date, patients with OA have hardly been considered a high-risk population for VTE. Our novel findings showed that the risk of ...

Utilizing machine learning techniques, the research aims to develop an interpretable VTE risk prediction model. The goal is to identify patients with gastric or esophageal cancer who are at high risk ...

The population of interest in our study included a very broad range of medical patients, and not just those with high-risk conditions. The risk among patients with known risk factors for VTE ...

The first step in preventing death and disability from VTE is to identify those at risk so that preventative treatments (prophylaxis) can be given. This data collection quantifies the numbers of ...

A literature search identified six reports specifically addressing the issue of VTE risk in patients with cirrhosis. Reported rates of VTE development in such patients vary widely (0.5–8.2% ...

100% appropriately prescribed prophylaxis with significant increases in documentation of initial risk assessment and ongoing reassessments every 48 hours ... Maintaining the emphasis on trust wide ...

Pulmonary embolism is a common cause of cardiovascular-associated morbidity and mortality. Although pulmonary embolism ...

A new study from Denmark has found that men who use anabolic androgenic steroids (AAS) have a much higher risk of developing ...